NCT00000267View on ClinicalTrials.gov

Risperidone Treatment in Dually-Diagnosed Individuals - 2

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

Not specified

Study Completion Date

December 31, 2001

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Risperidone

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

New York State Psychiatric Institute

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000267 - Risperidone Treatment in Dually-Diagnosed Individuals - 2 | Biotech Hunter | Biotech Hunter